Chronic Joint Pain in a Young Adult With Cystic Fibrosis

A 25-year-old male with end-stage cystic fibrosis (CF) with genotype F508del/F508del presented to the clinic complaining of bilateral knee and ankle pain. He had severe lung disease (forced expiratory volume 1 {FEV1} 19% of predicted), chronic colonization with achromobacter, malnutrition, and CF-related diabetes. On physical examination, he was found to have bilateral knee swelling as well as pain on flexion and extension of the wrists and ankles without erythema or warmth. He was empirically started on prednisone and tramadol; however, at a three-month follow-up visit, he remained symptomatic. He was sent for a whole-body bone scan, which was consistent with hypertrophic pulmonary osteoarthropathy (HPOA). He was started on highly effective modulator therapy with elexacaftor/tezacaftor/ivacaftor and symptoms spontaneously resolved without further intervention.

[1]  M. Martínez-Lavín.  Hypertrophic osteoarthropathy. , 2020, Best practice & research. Clinical rheumatology.

[2]  D. Staab,et al.  Clinical manifestations and risk factors of arthropathy in cystic fibrosis. , 2019, Respiratory medicine.

[3]  A. Kiani,et al.  Hypertrophic pulmonary osteoarthropathy: an unusual presentation , 2018, Rheumatology advances in practice.

[4]  M. Skalski,et al.  Hypertrophic Osteoarthropathy: Clinical and Imaging Features. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[5]  Mehrnaz Hojjati,et al.  Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy , 2010, Clinical Rheumatology.

[6]  D. Bonthron,et al.  Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy , 2008, Nature Genetics.

[7]  D. Nelson,et al.  Hypertrophic osteoarthropathy effectively treated with zoledronic acid. , 2008, Clinical lung cancer.

[8]  Stephen B. Fox,et al.  Vascular endothelial growth factor (VEGF)‐A and platelet‐derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing , 2004, The Journal of pathology.

[9]  Z. Kuloğlu,et al.  Hypertrophic osteoarthropathy in a child with biliary atresia , 2004, Scandinavian journal of gastroenterology.

[10]  T. Yoshimasu,et al.  Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma , 2001, Anti-cancer drugs.

[11]  C. Pineda,et al.  Vascular endothelial growth factor and hypertrophic osteoarthropathy. , 2000, Clinical and experimental rheumatology.

[12]  P. Merkel,et al.  Rheumatic disease and cystic fibrosis. , 1999, Arthritis and rheumatism.

[13]  A. Bakkaloğlu,et al.  Antineutrophil Cytoplasmic Antibodies in Juvenile Chronic Arthritis , 1999, Clinical Rheumatology.

[14]  R. Howman-Giles,et al.  The musculoskeletal complications of cystic fibrosis , 1998, Journal of paediatrics and child health.

[15]  C. Pineda,et al.  Features of hypertrophic osteoarthropathy in patients with POEMS syndrome: a metaanalysis. , 1997, The Journal of rheumatology.

[16]  I. Belton,et al.  Hypertrophic osteoarthropathy in staging skeletal scintigraphy for lung cancer. , 1996, Clinical radiology.

[17]  M. Corey,et al.  The musculoskeletal manifestations of cystic fibrosis. , 1986, Seminars in arthritis and rheumatism.

[18]  T. David,et al.  Pathogenesis and management of arthropathy in cystic fibrosis. , 1986, Journal of the Royal Society of Medicine.

[19]  F. Attié,et al.  Hypertrophic osteoarthropathy in cyanotic congenital heart disease: its prevalence and relationship to bypass of the lung. , 1982, Arthritis and rheumatism.